High autoantibody levels inhibit the INSR (antagonistic role), causing insulin resistance and hyperglycemia, while low levels of these autoantibodies partially agonize insulin-mimetic activity, causing hypoglycemia [66,67,68]. This evidence concerns the gene INS and Hypoglycemia.